Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

5902 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
71-19     OXAROL Injection Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs
71-20     Fycompa Eisai Co., Ltd. (エーザイ株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs
71-21     サムタス Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs
71-22     サムタス Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社) Original drug not imported to China Approved in Japan The 71st Batch of Reference Listed Drugs
71-23 NOXAFIL Merck Sharp & Dohme B.V. Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs
71-24 / IPSEN Consumer HealthCare Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs
71-25 OTEZLA (欧泰乐) Amgen Inc. Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs
71-26 OTEZLA (欧泰乐) Amgen Inc. Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs
71-27 Verquvo Bayer AG Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs
71-28 Verquvo Bayer AG Original drug approved in China Original drug imported to China The 71st Batch of Reference Listed Drugs